5 Reasons to Love Scott Rocklage
In the modern American business culture, it is all too common to find people in positions of leadership they are not prepared for, or to be discouraged at the inexperience of a leadership team. Scott Rocklage stands above the rest; here are five reasons why.
1.) Leadership- He has unparalleled experience in the medical research and venture capital field- With over 30 years of leadership experience as President, Chairman of the Board, CEO, co-founder and trustee at the Nation’s top medical and venture capital companies, Dr. Rocklage has proven his ability to lead any team and work with executives and staff alike.
2.) Education- His PhD was obtained from MIT and Bachelors of Science in Chemistry from the University of California. MIT is world renown for excellent in scientific education and challenges all students to reach success- a value clearly seen in Scott Rocklage’s life and learn more about Scott.
3.) A track record of success- Throughout his lifetime Dr. Rocklage has been responsible positions through trials and approval process crucial to bringing FDA approval of three new drugs, and is inventor or co-inventor of over 300 U.S. patents and Scott’s lacrosse camp.
4.) Collaboration- During his career, companies including Cubist Pharmaceuticals, Nycomed Salutar, Relypsa and Catalytica have all listed Dr. Rocklage among their leadership team. In 2003 he joined 5AM Ventures as a Venture Partner and became a Managing Partner in 2004. He also currently serves as Board Chairman of Rennovia, Kinestral and Cidara. Furthermore, he also on the boards of Epirus and Pulmatrix and his Linkedin.
5.) A giving spirit- Dr. Rockladge was recently praised by MIT for his giving to the renovation of the Lester Wolfe Professor of Chemistry and Moungi Bawendi’s nanochemistry and nanotechnology labs. Rocklage stated he was honored to help with the needs of a noble-winning educational environment that he is proud to be part of.
5AM Ventures is truly thankful to have someone who is an innovator with a track record of getting results be part of the team. His knowledge of the medical industry gives him a unique perspective at understanding the venture capital market surrounding medical advancement and more information click here.